Purchase Order 75N93018P00631

Genscript USA Incorporated will provide gene synthesis and vector ark cloning services to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS). Under the terms of a $12,108 firm fixed price purchase order, Genscript will deliver the requested products and services between September 2023 and September 2024. As the prime contractor, Genscript will leverage its expertise...

Genscript USA Incorporated will provide gene synthesis services to the National Institutes of Health's National Institute of Allergy and Infectious Diseases under a $12,500 firm fixed price purchase order. The one-year contract was awarded on September 14, 2023 and runs through September 13, 2024. Genscript will deliver the gene synthesis work from its location in Piscataway, New Jersey. No subcontractors or additional context were provided regarding the specific research being supported under...

This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Synbio Technologies LLC, a small business located in Monmouth Junction, New Jersey. The $11,994.20 contract is for the delivery of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag. The requirement was originally posted as a special notice by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious...

Promega Corporation was awarded a $238,729.80 firm fixed price call against the Biomedical Product Support Blanket Purchase Agreement by the Defense Health Agency to deliver 250 units of Proteinase K solution. Under this contract, Promega Corp will provide the requested proteolytic enzyme solution to support the Agency's biomedical research programs. The place of performance is Madison, Wisconsin and there is no set-aside designation. Promega will be the prime contractor on this contract to...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $250,000 firm fixed price purchase order to Genscript USA Inc. of Piscataway, New Jersey. The order is for gene production and protein expression services to support the agency's research efforts. Services include gene synthesis, cloning, plasmid preparation, and protein expression and purification. The sole source award was negotiated under the authority of 41 U.S.C. 1901(a)(1) based on...

This federal contract was awarded by the Plains Area division of a civilian federal agency to Genscript USA Inc., a biotechnology company based in New Jersey. The $3,458.11 firm fixed-price purchase order is for protein expression and purification services. The contract does not have a set-aside designation. Genscript has received numerous prime and subcontract awards from federal agencies like the Department of Health and Human Services (including the National Institutes of Health, Centers...

This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $21,095.60 contract is for the provision of custom gene synthesis services to support NIAID's biomedical research and public health initiatives. Genscript USA Inc. is an experienced federal contractor, having received numerous...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the U.S. Department of Health and Human Services (HHS) to Allele Biotechnology and Pharmaceuticals, Inc. for the development of novel protein expression technologies for glycosylated cancer-related proteins. The contract has a ceiling value of $150,000 and was awarded on September 30, 2009, with a completion date of March 30, 2010. Allele Biotechnology is a minority-owned, for-profit small business based in San...

This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Aldevron, L.L.C., a for-profit limited liability company and manufacturer of biological products. The $7,930.00 contract is for the provision of 7 units of custom plasmid purification with endotoxin requirement, at a unit price of $1,125.00. This contract supports medical research and development efforts,...

The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) awarded a $37,889.60 firm fixed-price purchase order contract to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, for custom gene synthesis and expression services. This requirement was sole-sourced to Genscript due to their specialized expertise in producing the specific gene constructs needed to support NIAID's vaccine research and development efforts. The contract...